[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Clinical Expertise

  • Acute Myeloid Leukemia

About

Dr. Kim's goal is to develop chimeric antigen receptor T cells as a safe and effective therapy for AML. To this end, I am exploring different target antigens for CAR T cell therapy, investigating mechanisms to enhance the anti-tumor effect of CAR T cells, and finding methods to circumvent the toxicity associated with T cell immunotherapy in the setting of myeloid malignancies.

Location

Washington University School Of Medicine: 660 S Euclid Ave, St. Louis, MO 63110, USA

newsletter icon

Get the latest thought leadership on your Leukemia delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.